Table 2.
Variables | Gray’s Test | P-value | Cumulative Incidence Function | ||
---|---|---|---|---|---|
12-mo | 36-mo | 60-mo | |||
Age | 0.119 | 0.729 | |||
≥70years | 0.229 | 0.477 | 0.517 | ||
<70years | 0.174 | 0.421 | 0.522 | ||
Sex | 1.665 | 0.197 | |||
Male | 0.201 | 0.460 | 0.583 | ||
Female | 0.163 | 0.391 | 0.425 | ||
Child-pugh score | 0.745 | 0.388 | |||
B | 0.250 | 0.250 | 0.594 | ||
A | 0.180 | 0.444 | 0.525 | ||
HbsAg | 0.224 | 0.636 | |||
Positive | 0.212 | 0.418 | 0.529 | ||
Negative | 0.171 | 0.436 | 0.518 | ||
Portal hypertension | 2.649 | 0.104 | |||
Present | 0.136 | 0.318 | 0.415 | ||
Absent | 0.230 | 0.460 | 0.546 | ||
CA19-9 level | 6.672 | 0.010 | |||
>79 U/mL | 0.247 | 0.524 | 0.569 | ||
≤79 U/mL | 0.128 | 0.346 | 0.477 | ||
Maximum tumor size | 5.653 | 0.017 | |||
>5cm | 0.243 | 0.508 | 0.609 | ||
≤5cm | 0.121 | 0.344 | 0.412 | ||
Tumor number | 4.721 | 0.030 | |||
Multiple | 0.310 | 0.552 | 0.581 | ||
Single | 0.128 | 0.378 | 0.493 | ||
Tumor encapsulation | 1.575 | 0.209 | |||
Incomplete | 0.202 | 0.508 | 0.547 | ||
Complete | 0.167 | 0.348 | 0.489 | ||
MVI | 19.429 | <0.001 | |||
Yes | 0.357 | 0.724 | 0.775 | ||
No | 0.146 | 0.365 | 0.463 | ||
Macroscopic vascular invasion | 35.591 | <0.001 | |||
Yes | 0.358 | 0.679 | 0.761 | ||
No | 0.113 | 0.323 | 0.412 | ||
Satellite nodules | 4.260 | 0.039 | |||
Yes | 0.232 | 0.622 | 0.811 | ||
No | 0.178 | 0.407 | 0.487 | ||
Lymph node metastasis | 7.687 | <0.001 | |||
Yes | 0.306 | 0.662 | 0.683 | ||
No | 0.149 | 0.363 | 0.472 | ||
Extent of liver resection | 0.243 | 0.622 | |||
Major | 0.226 | 0.442 | 0.529 | ||
Minor | 0.140 | 0.421 | 0.512 | ||
Operation approach | 0.594 | 0.441 | |||
LLR | 0.222 | 0.575 | 0.575 | ||
OLR | 0.182 | 0.421 | 0.514 |
Note: Bold indicates statistically significant difference.
Abbreviations: HBsAg, hepatitis B surface antigen; CA19-9, carbohydrate antigen 19–9; MVI, microvascular invasion; LLR, laparoscopic liver resection; OLR, open liver resection.